IRCT20180103038199N17
Not yet recruiting
Phase 2
A pilot study on the safety and effectiveness of celiac support capsule on clinical symptoms in patients suffering from celiac disease
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mashhad University of Medical Sciences
- Enrollment
- 12
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Having celiac disease
- •Age between 5 to 30 years
- •Not suffering from other diseases
- •Normal liver and kidney status
- •Not pregnant
Exclusion Criteria
- •The occurrence of drug allergy
- •Occurrence of clinical symptoms of celiac disease within 48 hours
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
CAL(Cell assisted lipo-transfer) in treating recurrent complex anal fistulaKCT0008334Hangun Hospital Bumcheon Campus20
Recruiting
Not Applicable
A pilot study regarding efficacy and safety of combination therapy with angiotensin receptor blocker and renin inhibitor for patients with chronic heart failure combined with hypertension and diabetesJPRN-UMIN000004059Osaka Medical College60
Completed
Phase 2
A study investigating the efficacy and safety of CNS prophylaxis with R-CHOP and high-dose methotrexate in patients with de novo diffuse large B-cell lymphoma who have high risk for CNS relapse.Diffuse large B-cell lymphomaJPRN-UMIN000013540Department of Hematology and Oncology, Osaka University Graduate School of Medicine100
Recruiting
Not Applicable
A safety and efficacy pilot study on the use of a continuous distraction spring in addition to growing rod surgery in children with congenital, neuromuscular or idiopathic spinal deformities.ScoliosescoliosisSpinal growth deformitiesNL-OMON56121niversitair Medisch Centrum Utrecht160
Active, not recruiting
Phase 1
An evaluation of the safety and effectiveness of combination therapy using the thiazolidinedione pioglitazone alongside insulin in type 2 diabetes mellitus.EUCTR2006-001982-41-GBBradford Teaching Hospitals NHS Foundation Trust40